7-14-2021The U.S. Department of Health and Human Services (HHS) recently published two updates to its Guidelines for the Prevention and Treatment of Opportunistic Infect…
6-16-2021Cross-posted from NIH NewsroomA clinical trial is underway in five U.S. cities to determine whether delivering integrated health services through mobile clinics…
5-27-2021Cross-posted from Centers for Disease Control and PreventionMay 27, 2021Dear Colleague,Today, the Centers for Disease Control and Prevention (CDC) published thr…
3-11-2021As the 2021 virtual Conference on Retroviruses and Opportunistic Infections (CROI) concluded, NIH’s Dr. Carl Dieffenbach joined HIV.gov for a conversation abo…
2-3-2021The HHS Substance Abuse and Mental Health Services Administration (SAMHSA) has released Prevention and Treatment of HIV Among People Living with Substance Use a…
1-22-2021@US_FDA has approved Cabenuva (cabotegravir and rilpivirine), the first injectable, complete treatment regimen for people with #HIV that is administered once a …
12-3-2020Cross-posted from NIAID NewsroomGrant Awards Set Stage for Next Seven Years of Science-Driven HIV Clinical ResearchThe National Institute of Allergy and Infec…
10-19-2020As one of several Indian Health Service activities supported by the Minority HIV/AIDS Fund (MHAF) in Fiscal Year 2020, the Urban Indian Health Institute (UIHI) …
9-16-2020The Centers for Disease Control and Prevention (CDC) is rolling out a new suite of HIV Treatment Works (HTW) products and materials as part of its Let’s Stop …
9-14-2020Cross-posted from the Office of AIDS ResearchThe NIH Office of AIDS Research (OAR) is pleased to announce the transition of the public AIDSinfo.nih.gov and inf…
